Mortality in Parenchymal and Subarachnoid Neurocysticercosis.
Journal
The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507
Informations de publication
Date de publication:
07 07 2021
07 07 2021
Historique:
received:
13
10
2020
accepted:
07
01
2021
entrez:
7
7
2021
pubmed:
8
7
2021
medline:
8
9
2021
Statut:
ppublish
Résumé
Neurocysticercosis (NCC) is endemic in many parts of the world, carrying significant neurological morbidity that varies according to whether lesions are located inside the cerebral parenchyma or in extraparenchymal spaces. The latter, in particular subarachnoid NCC, is assumed to be more severe, but no controlled studies comparing mortality between types of NCC exist. The aim of this study was to compare all-cause mortality between patients with intraparenchymal NCC and those with subarachnoid NCC. Vital status and sociodemographic characteristics were evaluated in patients with intraparenchymal viable, intraparenchymal calcified, and subarachnoid NCC attending a neurological referral hospital in Lima, Perú. Survival analyses using Kaplan-Meier curves and Cox proportional regression models were carried out to compare mortality rates between groups. From 840 NCC patients followed by a median time of 82.3 months, 42 (5.0%) died, six (1.8%) in the intraparenchymal viable group, four (1.3%) in the calcified group, and 32 (16.6%) in the subarachnoid group (P < 0.001). Older age and lower education were significantly associated with mortality. The age-adjusted hazard ratio for death in the subarachnoid group was 13.6 (95% CI: 5.6-33.0, P < 0.001) compared with the intraparenchymal viable group and 10.7 (95% CI: 3.7-30.8, P < 0.001) when compared with the calcified group. We concluded that subarachnoid disease is associated with a much higher mortality in NCC.
Identifiants
pubmed: 34232912
doi: 10.4269/ajtmh.20-1330
pii: tpmd201330
pmc: PMC8274779
doi:
pii:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
176-180Subventions
Organisme : FIC NIH HHS
ID : D43 TW001140
Pays : United States
Références
Br J Clin Pharmacol. 2011 Jul;72(1):77-84
pubmed: 21332573
Acta Trop. 2013 Oct;128(1):18-26
pubmed: 23871891
N Engl J Med. 2004 Jan 15;350(3):249-58
pubmed: 14724304
Cad Saude Publica. 2007 Dec;23(12):2917-27
pubmed: 18157334
Acta Neurochir (Wien). 2005 Jul;147(7):785-6; discussion 786
pubmed: 15821862
Rev Soc Bras Med Trop. 2012 Mar-Apr;45(2):280
pubmed: 22535012
Clin Microbiol Rev. 2020 May 27;33(3):
pubmed: 32461308
Ann Neurol. 2019 Dec;86(6):951-961
pubmed: 31621936
Lancet Neurol. 2014 Dec;13(12):1202-15
pubmed: 25453460
Expert Rev Anti Infect Ther. 2011 Jan;9(1):123-33
pubmed: 21171883
PLoS Negl Trop Dis. 2013 Oct 31;7(10):e2480
pubmed: 24205415
Emerg Infect Dis. 2002 Jun;8(6):608-13
pubmed: 12023918
Clin Infect Dis. 2020 Jun 17;:
pubmed: 32556276
PLoS Negl Trop Dis. 2012;6(2):e1521
pubmed: 22363827
Epilepsia. 2014 Sep;55(9):1452-9
pubmed: 25092547
World Neurosurg. 2012 Jul;78(1-2):155-63
pubmed: 22120565
Emerg Infect Dis. 2007 Feb;13(2):230-5
pubmed: 17479884
Neurosurg Focus. 2002 Jun 15;12(6):e2
pubmed: 15926781
PLoS Negl Trop Dis. 2019 Jul 10;13(7):e0007501
pubmed: 31291239
Expert Opin Drug Saf. 2015 Apr;14(4):553-8
pubmed: 25645424
Am J Trop Med Hyg. 2020 Jan;102(1):78-89
pubmed: 31642423
Clin Infect Dis. 2018 Jan 6;66(2):282-288
pubmed: 29020381
Acta Trop. 2016 Jan;153:128-36
pubmed: 26505283
Am J Forensic Med Pathol. 2010 Jun;31(2):117-9
pubmed: 20139756
Lancet Neurol. 2008 Dec;7(12):1099-105
pubmed: 18986841
Neurology. 2012 May 1;78(18):1394-400
pubmed: 22517102
Epilepsy Behav. 2018 Oct;87:213-225
pubmed: 30154056
Lancet Infect Dis. 2014 Aug;14(8):687-695
pubmed: 24999157
Clin Infect Dis. 2016 Jun 1;62(11):1375-9
pubmed: 26984901